Biotech Stocks Facing FDA Decision In July 2026
LONDON (dpa-AFX) - July is here, and the FDA is set to announce decisions on therapies for conditions ranging from breast cancer and IgA nephropathy to multiple myeloma, ADHD, and wet AMD.Before turning our attention to the key FDA decisions expected in July, here are some of the newsworthy regulat…